At a glance
ClinicalIndex Comparison RecordN/ACompleted· 39 enrolled
Drug / intervention
Fructose + Glucose Beverageother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
In Brief
A clinical study evaluating Fructose + Glucose Beverage for Elevated Triglycerides and 3 related conditions. Completed, enrolled 39 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine whether hepatic de novo lipogenesis (DNL) in response to the ingestion of a mixture of glucose and fructose is greater in South Asians compared to controls (Caucasians).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsElevated Triglycerides, Diabetes, Cardiovascular Disease, Dyslipidemia
CountriesUnited States
CollaboratorsWeill Medical College of Cornell University
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 2012
Enrollment StartApr 2012
Primary CompletionOct 2013
TodayJul 2026
First PostedMar 26, 2012
Enrollment StartApr 2, 2012
Primary CompletionOct 10, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.3 years ago
Interventions
Fructose + Glucose Beverageother
Consumption of a sweet beverage (Fructose:Glucose 1:1, 3g/kg) over 1/2 hour. Blood sampling will occur before and after consumption of beverage.